Entero Therapeutics
NASDAQ: ENTO

Healthcare
Biotechnology
Global Rank
#45910
Country Rank
#5628
Market Cap
2.91 M
Price
0.61
Change (%)
0.54%
Volume
337,470
Entero Therapeutics (NASDAQ: ENTO) Stock Split History
This company has undergone a total of five stock splits throughout its history. Five reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on 08/18/2025 with a ratio of 1-for-3. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Date | Split Ratio | Multiple | Cumulative multiple | Type |
---|---|---|---|---|
08/18/2025 | 1:3 | x0.3333333 | x0.000007936509 | Reverse |
12/18/2023 | 1:20 | x0.05 | x0.00002380953 | Reverse |
01/18/2023 | 1:7 | x0.1428571 | x0.0004761905 | Reverse |
08/26/2022 | 1:30 | x0.03333334 | x0.003333334 | Reverse |
09/13/2021 | 1:10 | x0.1 | x0.1 | Reverse |
Frequently Asked Questions
-
How much would Entero Therapeutics stock be worth if it never split?If Entero Therapeutics (stock symbol: NASDAQ: ENTO) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-3) that occurred on 08/18/2025.
-
Has Entero Therapeutics stock ever split?Entero Therapeutics (stock symbol: NASDAQ: ENTO) has undergone a total of five stock splits. The most recent split occurred on 08/18/2025. One share bought prior to the first split on 09/13/2021 would now equal 0.00 shares.
-
Will Entero Therapeutics stock split again?Entero Therapeutics (stock symbol: NASDAQ: ENTO) has undergone five stock splits in its history. The most recent split, a 1-for-10 split, occurred on 08/18/2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.